MySize, Inc. Issues CEO Letter to Shareholders: Key Updates, Nasdaq Non-Compliance, and Financials

Summary

• Nasdaq Non-Compliance Notice: MySize received notice from Nasdaq for not meeting the \$1.00 minimum bid requirement for 30 consecutive trading days. The company has until August 31, 2026, to regain compliance.
• Financial Update for 2025: Approximately \$10 million in revenue generated across the platform, with key business units highlighted for growth and margin improvements.
• Strategic Expansion: Launch of 10peaks, a new higher-margin subsidiary, and continued momentum across Orgad, Naiz Fit, and Percentil.
• Management’s Outlook: Focus remains on execution, revenue growth, and increasing higher-margin business activities.

Detailed Report

Nasdaq Minimum Bid Price Non-Compliance

On March 2, 2026, MySize, Inc. (NASDAQ: MYSZ) received formal notification from The Nasdaq Stock Market that the company’s common stock had closed below \$1.00 for 30 consecutive trading days. As a result, MySize faces the risk of delisting if it does not regain compliance within 180 calendar days (by August 31, 2026). To regain compliance, the closing bid price must be at least \$1.00 per share for a minimum of 10 consecutive business days.

Importantly, this notice does not affect MySize’s ongoing operations, relationships with customers, or its financial position. The stock remains listed and continues trading under the ticker MYSZ.

If compliance is not achieved by the deadline, MySize may be eligible for an additional 180-day grace period, provided it meets other Nasdaq listing requirements (except the bid price). If compliance cannot be regained, Nasdaq could initiate delisting procedures, which the company would have an opportunity to appeal.

Business Performance and Segment Highlights

• 2025 Preliminary Revenue: MySize generated approximately \$10 million in revenue in 2025, demonstrating scale and momentum across its diversified platform.
• Orgad: The Amazon-focused overstock and infrastructure business brought in stable revenues with impressive gross margins of about 40% for the year. Orgad’s stability supports the company’s expansion into higher-margin activities.
• 10peaks: Launched in September 2025, 10peaks is a wholly owned regional distribution and retail subsidiary operating in Israel, Greece, Cyprus, and Malta. In its first year, 10peaks generated approximately \$150,000 in revenue and operated at around 65% gross margin before operating expenses. Management estimates annual revenues could reach ~\$3 million based on current commercial assumptions. 10peaks has secured distribution agreements with brands including Fabletics, Rigorer, Craft, Fitvilly, and X-Bionic, and utilizes MySize’s sizing technology to improve customer experience and reduce returns. The subsidiary is run as a separate legal entity for accountability and agility.
• Naiz Fit: Continues to serve enterprise clients with AI sizing solutions for apparel and footwear, focused on reducing returns and improving conversion rates.
• Percentil: Operates a managed secondhand marketplace across key European markets, providing another avenue to monetize excess inventory.

Strategic Direction and Management Commentary

CEO Ronen Luzon emphasized that the company’s strategy centers on execution and long-term value creation. By growing revenues, increasing the contribution of higher-margin business activities, and leveraging synergies across its business units, MySize aims to improve operating leverage and overall profitability.

The CEO also acknowledged the importance of the share price and committed to disciplined execution as the best remedy for the current Nasdaq compliance situation.

Risks and Forward-Looking Statements

• Preliminary financial results for 2025 are unaudited and may differ from final audited figures. Investors should not place undue reliance on the preliminary data.
• Forward-looking statements, including projections for 10peaks and plans to regain Nasdaq compliance, are subject to significant risks and uncertainties.
• Trading in MySize shares may be volatile given the compliance risk, ongoing financial performance, and execution of its strategic plans.

What Investors Should Watch

• Nasdaq Compliance Deadline: August 31, 2026 – MySize must close at or above \$1.00 for 10 consecutive business days to avoid delisting risk.
• Growth and Margin Expansion: Progress in scaling 10peaks, improving margins, and expanding Orgad and Percentil.
• Final Audited Results for 2025: Investors should review the company’s official filings for final numbers and any material changes.
• Potential Share Price Sensitivity: Shareholders should be aware that the risk of delisting and the company’s ability to execute on its growth strategy could lead to significant share price movements.

Contact

For more details, shareholders and investors can contact Oren Elmaliah, Chief Financial Officer, at [email protected] or visit www.mysizeid.com.

Disclaimer

The information provided above is a summary based on preliminary, unaudited results and forward-looking statements. These statements are subject to risks, uncertainties, and changes based on future events and final audited outcomes. Investors are encouraged to review the company’s filings with the U.S. Securities and Exchange Commission and consult with their financial advisors before making investment decisions. This article does not constitute investment advice.

View My Size, Inc. Historical chart here